Deriving a reduced lead system from the 80-lead body surface map for the electrocardiographic determination of acute myocardial infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32335049

Enrollment

400

Registered

2008-05-30

Start date

2006-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndromes Circulatory System Acute myocardial infarction

Interventions

All participants will be assessed by both Reduced Lead Body Surface Map and 12 Lead ECG. All management decisions will be made using the 12 Lead ECG only (as is current practice).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients presenting to the Regional Medical Cardiology Centre, Royal Victoria Hospital, with ischaemic type chest pain >20 minutes duration.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have the following prior to the initial 12-lead ECG or reduced lead system application: 1. Pain <20 minutes 2. Receive fibrinolytic therapy 3. Nitrates or glycoprotein inhibitors

Design outcomes

Primary

Measure	Time frame
Improved diagnostic yield of Body Surface Map over the 12 lead ECG	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026